HCA
REPL icon

Harbor Capital Advisors’s Replimune Group REPL Stock Holding History

Harbor Capital Advisors’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-41,715
Closed -$341K – 760
2024
Q1 		$341K Buy
41,715
+9,404
+29% +$77.1K 0.04% 493
2023
Q4 		$272K Buy
32,311
+1,844
+6% +$21.4K 0.05% 330
2023
Q3 		$521K Buy
30,467
+4,699
+18% +$92.3K 0.11% 220
2023
Q2 		$598K Buy
25,768
+2,336
+10% +$45.6K 0.12% 205
2023
Q1 		$414K Sell
23,432
-3,629
-13% -$86.3K 0.12% 156
2022
Q4 		$736K Sell
27,061
-583
-2% -$12.1K 0.71% 50
2022
Q3 		$477K Sell
27,644
-3,051
-10% -$58.2K 0.44% 66
2022
Q2 		$537K Buy
30,695
+513
+2% +$8.43K 0.41% 68
2022
Q1 		$512K Sell
30,182
-6,923
-19% -$131K 0.24% 77
2021
Q4 		$1.01M Buy
+37,105
New +$1.11M 0.37% 74

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Harbor Capital Advisors's REPL Position: Q2 2024 in Review

Harbor Capital Advisors sold out of Replimune Group (REPL) in Q2 2024, closing a stake of 41,715 shares — an estimated $341K sold.

Harbor Capital Advisors first reported a position in REPL in Q4 2021 and held it in 10 quarters. The position peaked at $1.01M in Q4 2021. 149 funds tracked by Wall St. Rank hold REPL as of Q2 2024.

  • Harbor Capital Advisors reported no remaining Replimune Group position as of Q2 2024 after selling out during the quarter.
  • Harbor Capital Advisors sold 41,715 Replimune Group shares in Q2 2024, an estimated $341K.
  • Harbor Capital Advisors first reported a position in Replimune Group in Q4 2021 and held it in 10 quarters.
  • Harbor Capital Advisors's Replimune Group position peaked at $1.01M in Q4 2021.
  • 149 funds tracked by Wall St. Rank held Replimune Group as of Q2 2024.

Based on Harbor Capital Advisors's 13F filing for Q2 2024, filed 9 Jul 2024.